Neuca expects gross profitability to increase in the short and long term

Neuca expects an improvement in gross profitability in the short and long term, said president Piotr Sucharski. In Q1 this year. gross margin on sales increased by 0.57 percentage points. y / y to 11.44%.

“Our sustainability ambition is not to cut margins. We would like to grow in this area as well. It is the increase in the scale of operations, the growing scale of partner programs and the increasing share of the margin realized in clinical trials and patient businesses that give us hope, but in many cases the certainty that this margin will grow. This is what we expect both in the short and long term, ”Sucharski said during the press conference.

Vice-president for finance, Grzegorz Dzik, assessed that the growing gross margin will allow the company to compensate for the expected increase in costs.

The Neuca Group is a market leader in the wholesale of drugs. The total share of the Neuca group companies in the domestic pharmacy wholesale market at the end of 2021 was 31.7%. The Group is also developing a network of medical clinics, is an expert in the clinical trials segment, implements telemedicine projects and invests in health insurance.


Our privacy policy